Advertisement
SARTF vs SDMHF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SARTF is a Hold and SDMHF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SARTF’s FA Score shows that 0 FA rating(s) are green whileSDMHF’s FA Score has 0 green FA rating(s).
- SARTF’s FA Score: 0 green, 5 red.
- SDMHF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SARTF’s TA Score shows that 4 TA indicator(s) are bullish while SDMHF’s TA Score has 4 bullish TA indicator(s).
- SARTF’s TA Score: 4 bullish, 5 bearish.
- SDMHF’s TA Score: 4 bullish, 6 bearish.
Price Growth
SARTF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SDMHF (@Pharmaceuticals: Other) price change was -1.51% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.
Industries' Descriptions
@Pharmaceuticals: Other (+1.86% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| SARTF | SDMHF | SARTF / SDMHF | |
| Capitalization | 13.3B | 18.9B | 70% |
| EBITDA | 844M | 740M | 114% |
| Gain YTD | 0.144 | 0.513 | 28% |
| P/E Ratio | 105.35 | 72.76 | 145% |
| Revenue | 3.47B | 2.9B | 120% |
| Total Cash | 872M | 745M | 117% |
| Total Debt | 4.66B | 2.97B | 157% |
SARTF | SDMHF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 86 | 83 | |
PRICE GROWTH RATING 1..100 | 83 | 82 | |
P/E GROWTH RATING 1..100 | 91 | 84 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SDMHF's Valuation (76) in the null industry is in the same range as SARTF (78). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.
SDMHF's Profit vs Risk Rating (100) in the null industry is in the same range as SARTF (100). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.
SDMHF's SMR Rating (83) in the null industry is in the same range as SARTF (86). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.
SDMHF's Price Growth Rating (82) in the null industry is in the same range as SARTF (83). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.
SDMHF's P/E Growth Rating (84) in the null industry is in the same range as SARTF (91). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.
| SARTF | SDMHF | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 50% | 4 days ago 69% |
| Stochastic ODDS (%) | 4 days ago 66% | 4 days ago 68% |
| Momentum ODDS (%) | 4 days ago 51% | 4 days ago 52% |
| MACD ODDS (%) | 4 days ago 70% | 4 days ago 44% |
| TrendWeek ODDS (%) | 4 days ago 55% | 4 days ago 56% |
| TrendMonth ODDS (%) | 4 days ago 69% | 4 days ago 48% |
| Advances ODDS (%) | N/A | 13 days ago 67% |
| Declines ODDS (%) | N/A | 11 days ago 59% |
| BollingerBands ODDS (%) | 4 days ago 51% | 4 days ago 69% |
| Aroon ODDS (%) | 4 days ago 78% | 4 days ago 56% |
Advertisement
SARTF and
Correlation & Price change
A.I.dvisor indicates that over the last year, SARTF has been loosely correlated with SDMHF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SARTF jumps, then SDMHF could also see price increases.
| Ticker / NAME | Correlation To SARTF | 1D Price Change % | ||
|---|---|---|---|---|
| SARTF | 100% | N/A | ||
| SDMHF - SARTF | 39% Loosely correlated | +2.48% | ||
| SOAGY - SARTF | 27% Poorly correlated | +1.10% | ||
| EXAS - SARTF | 21% Poorly correlated | -5.03% | ||
| RSMDF - SARTF | 16% Poorly correlated | N/A | ||
| RYLPF - SARTF | 9% Poorly correlated | N/A | ||
More | ||||
SDMHF and
Correlation & Price change
A.I.dvisor indicates that over the last year, SDMHF has been loosely correlated with SOAGY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SDMHF jumps, then SOAGY could also see price increases.
| Ticker / NAME | Correlation To SDMHF | 1D Price Change % | ||
|---|---|---|---|---|
| SDMHF | 100% | +2.48% | ||
| SOAGY - SDMHF | 45% Loosely correlated | +1.10% | ||
| SARTF - SDMHF | 41% Loosely correlated | N/A | ||
| RPID - SDMHF | 30% Poorly correlated | +1.49% | ||
| JNDOF - SDMHF | 29% Poorly correlated | N/A | ||
| SRTOY - SDMHF | 22% Poorly correlated | +4.37% | ||
More | ||||